| 摘要 |
This invention is directed to novel azetidinone compounds, to certain intermediates and processes for preparing these azetidinone compounds, and to formulations containing the same. The present invention also relates to the use of these azetidinones as inhibitors of the enzymatic activity of Prostate-Specific Antigen (PSA) as well as for treating prostatic cancer (Pca), Pca metastasis, benign prostatic hyperplasia (BPH) and breast cancer (Bc). Another aspect of the invention relates to inventive methods for treating Pca, Pca metastasis, BPH and Bc by administering any PSA inhibiting compound. |
